Hamre M R, Robison L L, Nesbit M E, Sather H N, Meadows A T, Ortega J A, D'Angio G J, Hammond G D
Childrens Cancer Study Group Operations Office, Pasadena, CA 91101.
J Clin Oncol. 1987 Nov;5(11):1759-65. doi: 10.1200/JCO.1987.5.11.1759.
The Childrens Cancer Study Group has assessed serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and pubertal development in 97 long-term female survivors of childhood acute lymphoblastic leukemia (ALL). All patients received identical induction and maintenance therapy with either 18 or 24 Gy of radiation therapy (RT) to one of the following fields: cranial, craniospinal, or craniospinal plus 12 Gy abdominal RT including the ovaries. Thirty-six percent (35 patients) were found to have above normal levels of FSH and/or LH. The percentages of elevated values for RT fields were 93% for craniospinal plus abdominal RT, 49% for craniospinal RT, and 9% for cranial RT (P less than .001). A dose-response relationship was observed between 18 Gy and 24 Gy in females receiving only craniospinal RT (P = .01). Craniospinal plus abdominal RT and abnormal FSH/LH levels were significantly associated with lack of pubertal development and delayed onset of menses. Duration of maintenance chemotherapy was not associated with abnormal gonadotropin levels or the development of secondary sexual characteristics. Additional follow-up of this cohort is needed to establish the ultimate pubertal development and fertility of these patients.
儿童癌症研究组评估了97名儿童急性淋巴细胞白血病(ALL)女性长期幸存者的血清促卵泡激素(FSH)、促黄体生成素(LH)及青春期发育情况。所有患者均接受相同的诱导和维持治疗,对以下部位之一进行18或24 Gy的放射治疗(RT):颅脑、全脑全脊髓或全脑全脊髓加12 Gy腹部RT(包括卵巢)。结果发现,36%(35例患者)的FSH和/或LH水平高于正常。放射治疗部位FSH和/或LH水平升高的比例分别为:全脑全脊髓加腹部RT为93%,全脑全脊髓RT为49%,颅脑RT为9%(P<0.001)。仅接受全脑全脊髓RT的女性中,18 Gy与24 Gy之间观察到剂量反应关系(P = 0.01)。全脑全脊髓加腹部RT及FSH/LH水平异常与青春期发育缺失及月经初潮延迟显著相关。维持化疗的持续时间与促性腺激素水平异常或第二性征发育无关。需要对该队列进行进一步随访,以确定这些患者最终的青春期发育及生育情况。